All the news Showing 10 of 54 articles from: TreatmentGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection Gilead press release / 11 November 2016 HBV drug Tyzeka discontinued Healio Hepatology / 11 October 2016 New Tenofovir Formulation Provides Safer Hepatitis B Treatment Medscape (free registration required) / 03 October 2016 ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B ContraVir press release / 12 September 2016 Philippines FDA warns against fake Hepatitis C medicines GMA News / 31 May 2016 Antiviral therapy prolongs survival in immune tolerant hepatitis B patients Eurekalert Inf Dis / 15 April 2016 Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer EASL press release / 15 April 2016 ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study ContraVir press release / 30 March 2016 J&J signs deal with Chinese company for hepatitis B drug Reuters / 08 January 2016 Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection Gilead press release / 05 January 2016 ← Prev12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Transmission and prevention Diagnosis and monitoring Disease course and symptoms Treatment HIV and HBV HCV and HBV Hepatitis delta Living with HBV Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds